Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long‐acting dual amylin and calcitonin receptor agonist improves insulin‐mediated glycaemic control and controls body weight.
Saved in:
| Title: | Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long‐acting dual amylin and calcitonin receptor agonist improves insulin‐mediated glycaemic control and controls body weight. |
|---|---|
| Authors: | Melander, Simone Anna1 (AUTHOR) sme@nordicbio.com, Larsen, Anna Thorsø1 (AUTHOR), Karsdal, Morten Asser1,2 (AUTHOR), Henriksen, Kim1,2 (AUTHOR) |
| Source: | British Journal of Pharmacology. Jun2024, Vol. 181 Issue 12, p1829-1842. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 177145889 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long‐acting dual amylin and calcitonin receptor agonist improves insulin‐mediated glycaemic control and controls body weight. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Melander%2C+Simone+Anna%22">Melander, Simone Anna</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> sme@nordicbio.com</i><br /><searchLink fieldCode="AR" term="%22Larsen%2C+Anna+Thorsø%22">Larsen, Anna Thorsø</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Karsdal%2C+Morten+Asser%22">Karsdal, Morten Asser</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Henriksen%2C+Kim%22">Henriksen, Kim</searchLink><relatesTo>1,2</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22British+Journal+of+Pharmacology%22">British Journal of Pharmacology</searchLink>. Jun2024, Vol. 181 Issue 12, p1829-1842. 14p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=177145889 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bph.16329 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 14 StartPage: 1829 Titles: – TitleFull: Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long‐acting dual amylin and calcitonin receptor agonist improves insulin‐mediated glycaemic control and controls body weight. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Melander, Simone Anna – PersonEntity: Name: NameFull: Larsen, Anna Thorsø – PersonEntity: Name: NameFull: Karsdal, Morten Asser – PersonEntity: Name: NameFull: Henriksen, Kim IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 06 Text: Jun2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 00071188 Numbering: – Type: volume Value: 181 – Type: issue Value: 12 Titles: – TitleFull: British Journal of Pharmacology Type: main |
| ResultId | 1 |